Viridian Therapeutics Non Operating Income Net Other History
| VRDN Stock | USD 27.04 0.00 0.00% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 5.4 M | Current Value 5.7 M | Quarterly Volatility 2.3 M |
Macro event markers
Latest Viridian Therapeutics' Non Operating Income Net Other Growth Pattern
The historical Non Operating Income Net Other for Viridian Therapeutics spanning 4 fiscal years is captured in the chart. The growing trajectory is clearest when viewed across the full reporting window. The charted range provides context for evaluating whether recent figures represent a departure from trend. The pace of change matters as much as the direction when assessing Viridian Therapeutics' financial trajectory. The spread between Viridian Therapeutics' highest and lowest reported Non Operating Income Net Other defines the historical envelope.
| Non Operating Income Net Other | 10 Years Trend |
|
Non Operating Income Net Other |
| Timeline |
Non Operating Income Net Other Trend Statistics
| Arithmetic Mean | 1,592,540 | |
| Geometric Mean | 450,659 | |
| Coefficient Of Variation | 143.86 | |
| Mean Deviation | 2,014,879 | |
| Median | 165,000 | |
| Standard Deviation | 2,291,061 | |
| Sample Variance | 5.2T | |
| Range | 5.5M | |
| R-Value | 0.80 | |
| Mean Square Error | 2T | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | 363,341 | |
| Total Sum of Squares | 84T |
Viridian Therapeutics Non Operating Income Net Other History
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Other Operating Expenses | 434.2 M | 456 M | |
| Operating Income | -363.4 M | -345.2 M | |
| Total Operating Expenses | 433.1 M | 454.7 M | |
| Non Operating Income Net Other | 5.4 M | 5.7 M | |
| Total Cash From Operating Activities | -276.4 M | -262.6 M | |
| Change To Operating Activities | 5 M | 5.3 M | |
| Cash Flows Other Operating | -2.9 M | -2.8 M | |
| Operating Cash Flow Per Share | -3.26 | -3.42 | |
| EV To Operating Cash Flow | -8.96 | -9.41 | |
| Operating Cycle | 136.35 | 85.61 | |
| Price To Operating Cash Flows Ratio | -9.55 | -10.03 | |
| Operating Profit Margin | -5.13 | -5.39 | |
| Operating Cash Flow Sales Ratio | -3.90 | -4.10 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.00 | 1.12 |
Methodology, Assumptions & Data Sources
This chart follows Viridian Therapeutics's Non Operating Income Net Other across recent years. Year-over-year changes are the easiest way to spot turning points.
For Viridian Therapeutics, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Sell-side coverage, where present, supplements the data shown. Intraday timing differences may exist. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.